Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation. [electronic resource]
Producer: 20020416Description: 119-23 p. digitalISSN:- 0939-5555
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Combined Modality Therapy
- Hematopoietic Stem Cell Transplantation
- Humans
- Leukemia, Plasma Cell -- therapy
- Male
- Middle Aged
- Remission Induction
- Rituximab
- Transplantation, Autologous
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.